SHAP analysis further revealed that SMOC1 was the top-ranked feature driving separation between the Aβ+/tau+ and non-AD controls, while MLEC was the most important in classifying Aβ+/tau- AD patients (Fig. 5, E–G). The gene discussed is MAPT; the disease is Alzheimer disease.